REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/11/2026
Back to search
Official data from USPTO
CELLFX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
05/12/2026
Classification
Registered
Trademark type
Word
Nice classes
44
Filing date
01/09/2018
Registration date
05/11/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/11/2021
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/12/2021
First use in commerce
02/12/2021
Drawing code
4
Owner type
03
Owner location
HAYWARD, CA, US
Examiner
BLANDU, FLORENTINA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PULSE BIOSCIENCES, INC.
PULSE BIOSCIENCES, INC.
Representatives
Lena Vinitskaya
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Oncology, immunology and dermatology services using electric pulse technology; cosmetic medical services, namely, services for tissuemanipulation and modification; providing information in the field of oncology and medical and cosmetic tissue modification, manipulationand/or ablation using electric pulse technology; immunotherapeutic services for treating medical conditions; medical assistance servicesprovided through use of short electric pulses, including nanopulse electricity, for human and animal biomedical applications, including for theprevention, detection, diagnosis and treatment of medical conditions, diseases and injuries; medical assistance services through use ofnanopulse technology for ablation, manipulation or modification of biologic tissue; medical assistance services, namely, use of electric pulsetechnology for treatment of tumors, tissue growth, skin growth, warts, papilloma, and other medical conditions and disease, all of whichexclude services related to treatment of cellulite
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/08/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/25/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/24/2021
EX4G
SOU EXTENSION 4 GRANTED
03/24/2021
IUAF
USE AMENDMENT FILED
03/18/2021
EXT4
SOU EXTENSION 4 FILED
03/18/2021
EEXT
SOU TEAS EXTENSION RECEIVED
03/18/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/18/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2020
EX3G
SOU EXTENSION 3 GRANTED
09/12/2020
EXT3
SOU EXTENSION 3 FILED
09/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/12/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/19/2020
EX2G
SOU EXTENSION 2 GRANTED
03/17/2020
EXT2
SOU EXTENSION 2 FILED
03/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/17/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/10/2019
NOAC
CORRECTED NOA E-MAILED
10/10/2019
EX1G
SOU EXTENSION 1 GRANTED
10/09/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
10/09/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/05/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/04/2019
EXT1
SOU EXTENSION 1 FILED
08/29/2019
DRRR
DIVISIONAL REQUEST RECEIVED
08/29/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/29/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/29/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/24/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/26/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
02/13/2019
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/04/2019
APET
ASSIGNED TO PETITION STAFF
02/01/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/23/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/11/2018
PUBO
PUBLISHED FOR OPPOSITION
09/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/22/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2018
DOCK
ASSIGNED TO EXAMINER
07/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2018
ALIE
ASSIGNED TO LIE
06/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2018
GNRT
NON-FINAL ACTION E-MAILED
04/23/2018
CNRT
NON-FINAL ACTION WRITTEN
04/23/2018
DOCK
ASSIGNED TO EXAMINER
04/18/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2018
NWAP
NEW APPLICATION ENTERED
01/12/2018
Continuous trademark protection
Get notified about every new filing that threatens CELLFX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.